CYTOKINETICS INC (CYTK) › Capital ExpendituresCYTOKINETICS INC (CYTK) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $550.0K2010: $493.0K2011: $443.0K2012: $125.0K2013: $542.0K2014: $1.10M2015: $562.0K2016: $1.60M2017: $2.88M2018: $889.0K2019: $2.62M2020: $11.05M2021: $48.87M2022: $11.34M2023: $1.42M2024: $3.91M2025: $24.81M$24.81M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$24.81M+535.1%2024$3.91M+175.8%2023$1.42M-87.5%2022$11.34M-76.8%2021$48.87M+342.2%2020$11.05M+322.0%2019$2.62M+194.6%2018$889.0K-69.1%2017$2.88M+80.3%2016$1.60M+184.0%2015$562.0K-49.1%2014$1.10M+103.7%2013$542.0K+333.6%2012$125.0K-71.8%2011$443.0K-10.1%2010$493.0K-10.4%2009$550.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share